After being activated by antigen-presenting cells (APC), naive CD4 + T cells differentiate into helper T cells that acquire the ability to secrete effector cytokines. Helper T cells can be categorized into at least three subsets. T helper type 1 (T H 1) cells, which secrete interleukin 2 (IL-2) and the proinflammatory cytokines interferon (IFN-γ) and tumor necrosis factor (TNF), promote cellular immune responses mainly to intracellular pathogens and viruses. T H 2 cells secrete IL-4, IL-5, IL-6, IL-10 and IL-13 and promote humoral immune responses mainly to extracellular pathogens 1 . Cells of the T H 17 helper T cell subset, which secrete IL-17A, IL-17F and IL-22, mediate immune responses mainly to extracellular pathogenic bacteria and fungi 2 or have been linked to autoimmune disease 3 .
IL-13 was originally identified as a T H 2 cytokine 4 ; however, it is now known that IL-13 is produced by a variety of cell types, such as natural killer T cells (NKT cells), natural killer cells (NK cells), eosinophils and basophils 5 . As all of these cells also produce IL-4, it has been speculated that both IL-13 expression and IL-4 expression are controlled by common transcriptional mechanisms 6, 7 . However, T H 1 cells produce IL-13 in response to a combination of antigenic stimulation and IL- 18 (ref. 8) . Human patients with atopic or nonatopic asthma who have high titers of allergen-specific immunoglobulin E (IgE) can have more production of the T H 1 cytokine IFN-γ, along with substantially more IL-13 production 9, 10 . Therefore, T H 1 cells could also be a source of IL-13 because of their plasticity, which is controlled by chronic antigen stimulation. However, the molecular mechanisms that regulate the plasticity of IL-13 production in T H 1 cells is unclear. 11 . T H 17 cells also express IL-10 in the presence of IL-27 (ref. 12) . The mechanism by which IL-10 production is abrogated in T H 1 cells has been thought to be stable and immutable. However, IL-10 production by T H 1 cells has been reported in mice chronically infected with parasites such as Toxoplasma gondii 13, 14 or Leishmania major 15 . T H 1 cells also produce IL-10 in response to high-dose antigenic stimulation and hyperactivation of T cell antigen receptor (TCR)-mediated signaling leading to continuous phosphorylation of the mitogen-activated protein kinases Erk1 and Erk2. Mechanistically, activation of the transcription factor STAT4 seems to elicit this plasticity 16 . IL-10 is an immunoregulatory cytokine that can downregulate active immune responses and acts mainly on T cells or macrophages to attenuate inflammatory cytokine production and antigen presentation. IL-10-deficient mice die with spontaneous colitis 17 , and this phenotype is partly retained even in mice lacking IL-10 only in T reg cells 18 . IL-10 therefore has an important role regulating overactive responses that would otherwise result in autoinflammatory disease. The plasticity of IL-10 production by T H 1 cells in response to excess antigen stimuli could be an effective failsafe mechanism by which immune homeostasis is maintained. The differentiation of T H 1, T H 2 and T H 17 cells is regulated by distinct signaling pathways 19 . Despite differences in their developmental origin, these T cell subsets share the ability to make IL-10 (ref. 11) , although the molecular mechanisms that control this remain unclear.
IL-10 is also secreted by a wide variety of cells, such as T H 2 cells, NKT cells, NK cells, natural regulatory T cells (T reg cells), regulatory B cells, macrophages, dendritic cells (DCs) and monocytes

A r t i c l e s
The expression of Il10 and Il13 is regulated by GATA-3, the master transcriptional regulator for T H 2 differentiation. GATA-3 coordinately regulates a group of genes encoding T H 2 cytokines. Indeed, GATA-3 acts directly on the Il13 promoter 20 and initiates chromatin remodeling at the Il10 locus 21 . Activated T cell-specific conditional deletion of Gata3 markedly attenuates IL-13 expression in committed T H 2 cells 22 . However, IL-10 is also expressed by T H 1 cells and NK cells, which normally do not express GATA-3, and the mechanism by which IL-10 is expressed in the absence of GATA-3 remains unclear 16 . Therefore, an unknown regulator of plasticity may substitute for the function of GATA-3, particularly in these cell types.
E4BP4 (E4 promoter-binding protein 4) was originally identified as a basic leucine zipper transcription factor. E4BP4 regulates circadian rhythm by competing for DNA binding with a member of the related PAR family of basic leucine zipper transcription factors that has a DNA-binding domain similar to that of E4BP4. PAR factors have been characterized as transcriptional activators, whereas E4BP4 is a repressor. E4BP4 and the PAR proteins may switch back and forth between the on state and off state on target genes to control the central circadian clock 23 . In the immune system, E4BP4 is also known as NFIL-3, as it regulates the Il3 promoter and promotes IL-3-mediated cell survival 24, 25 . E4BP4 is a critical regulator of NK cell development through its induction of the transcriptional inhibitor Id2 (refs. 26,27) and also regulates IgE class switching in B cells 28 . Expression of the gene encoding E4BP4 (Nfil3; called 'E4bp4' here) is specific to T H 2 cells in both mice and humans 29, 30 . However, the functional importance of T H 2 cell-specific expression of E4BP4 is unclear.
In this study, we demonstrate that E4BP4 is the unknown factor important for the plasticity in the production of IL-10 and IL-13 by T H 1 cells after chronic antigen stimulation and that E4BP4 induced IL-10 production in the absence of GATA-3. Furthermore, E4BP4 regulated the transcription of Il10 and Il13 in natural T reg cells and NKT cells. However, IL-13 expression by T H 2 cells was independent of E4BP4, because T H 2 cells lacking E4bp4 did not produce IL-10 but IL-13 production was intact. Therefore, our data indicate that E4BP4 is a critical transcriptional regulator for IL-10, especially in CD4 + T cells. In addition, our data provide evidence of the functional importance of the expression of E4BP4 by T H 2 cells, in which it is an essential regulator of IL-10 production.
RESULTS
Plasticity in IL-13 production by T H 1 cells
In an airway hyper-responsiveness model, Il4 −/− and Il4r −/− mice lacking T H 2 cells still had substantial airway hyper-responsiveness, similar to that of control C57BL/6 mice. To confirm the involvement of IL-13 in this response, we isolated CD4 + T cells from bronchoalveolar lavage fluid and mesenteric lymph nodes of Il4 −/− mice. These T cells produced IL-13 ( Supplementary Fig. 1 ) despite their lack of detectable expression of GATA-3 protein. These results demonstrate that noncanonical IL-13-producing CD4 + T cells can be generated under T H 1-priming conditions. We speculated that repetitive T H 1 priming would engender plasticity in T H 1 cells, enabling them to express IL-13. To test our hypothesis, we obtained naive CD4 + T cells from mice transgenic for the ovalbumin (OVA)-specific TCR (DO11.10 mice), stimulated the cells weekly for 1-4 weeks (rounds 1-4 (R1-R4)) with OVA in the presence of APCs under T H 1-skewing conditions and analyzed cytokine production every week up to 4 weeks. As expected, abundant IFN-γ was induced after the initial antigen priming, and this gradually increased with serial stimulation. Although the cells never made IL-4 or IL-5, IL-13 was detectable after the third round of stimulation (R3), and this increased with further stimulation (Fig. 1a) . We observed similar IL-13-producing T H 1 cells derived from Il4r −/− and Stat6 −/− mice (Fig. 1b) , both of which have very Fig. 2 ).
Among these genes, 16 encoded molecules with features characteristic of transcription factors, and we confirmed their enhanced expression in R4 T H 1 cells by quantitative RT-PCR (Fig. 2a) . To determine which of the candidate genes encoded a molecule that could induce IL-13 expression, we ectopically expressed each in conventional T H 1 cells by retroviral transduction. Only overexpression of E4bp4 induced readily detectable IL-13 protein (Supplementary Fig. 3 ). In contrast, overexpression of Maf, Junb or Nr2c1, which all encode molecules thought to be regulators of T H 2 differentiation, did not induce IL-13 production by T H 1 cells (Fig. 2b) . However, IL-4 was nearly below the level of detection in the E4bp4-transduced cells (Fig. 2b) . The tempo of IL-13 production was accelerated in the transduced cells; single-cell analysis after intracellular cytokine staining demonstrated that more than 20% of the E4BP4-expressing cells produced IL-13 after only a single round of T H 1 stimulation (Fig. 2c) . 
A r t i c l e s
Published studies based on microarray data have shown E4bp4 expression mainly in T H 2 cells 29, 30 . We confirmed that finding but also found that E4bp4 mRNA was markedly enhanced in T H 1 cells after chronic T H 1 stimulation (Fig. 2d) . This promiscuous expression in both subsets was unique to E4bp4, as expression of mRNA for the transcription factor T-bet (Tbx21 mRNA) and Gata3 mRNA was limited to T H 1 and T H 2 cells, respectively. Next, to determine whether E4bp4 expression directly correlated with IL-13 expression at the single-cell level, we did immunofluorescence staining of R4 T H 1 cells generated from DO11.10 mice that lacked T H 2 cells because of Il4r deletion (Il4r −/− DO11.10 mice). E4BP4 protein was located mainly in the nucleus, and 90% of IL-13-producing cells had readily detectable E4BP4 expression (Fig. 2e) . As expected, IL-13 was coexpressed with IFN-γ in the stimulated cells (Fig. 2e) .
To test the generality of our observations in mice, we examined naive (CD45RA hi ) CD4 + T cells from human peripheral blood ( Supplementary Fig. 4a ). Three rounds of stimulation with monoclonal antibody (mAb) to CD3 under T H 1 conditions induced IL-13 production in ~9% of cells, of which ~97% were double producers of IL-13 and IFN-γ (Supplementary Fig. 4b ). These cells also had nuclear expression of E4BP4 protein, and about 90% of E4BP4-expressing cells CD4 + T cells produced IL-13 ( Supplementary Fig. 4c ). Therefore, there was a correlation between E4BP4 protein and IL-13 expression in human T H 1 cells after chronic TCR stimulation.
Expression of E4bp4, as well as of Gata3, was inducible in T H 2 cells 29, 30 (Fig. 2d) . To begin to assess the mechanisms of regulation of E4bp4 expression in T H 2 cells, we first tested the importance of the IL-4-STAT6 axis and confirmed that both neutralization of IL-4 and deficiency in Stat6 attenuated E4bp4 expression in T H 2-skewed cells (Supplementary Fig. 5 ). However, ectopic expression of Gata3 failed to induce E4bp4 expression ( Supplementary Fig. 5 ), which suggested that E4bp4 expression in T H 2 cells is regulated by the IL-4-STAT6 pathway and not by GATA-3.
E4bp4 regulates the expression of IL-13 and IL-10 in CD4 + T cells To study the role of E4BP4 in vivo, we established mice expressing a transgene encoding Flag-tagged E4BP4. Three independent lines had expression of Flag-tagged E4BP4 in 1-6% of CD4 + T cells (Fig. 3a) . Enforced expression of E4BP4 in CD4 + T cells resulted in more IL-13 production at 48 h after initial activation without affecting the production of IL-4 or IL-5 ( Fig. 3b) . Furthermore, this E4bp4 transgene also induced the expression of IL-3 as well as of IL-10 ( Fig. 3b) . The effect on IL-3 production was expected, as E4BP4 is a known inducer of this cytokine 24 ; however, the effect on IL-10 expression was completely unexpected. To further examine the possible regulation of both Il13 and Il10 by E4BP4, we assessed cytokine production and transgene expression in single cells. Production of IL-10 and IL-13 was augmented in cells expressing the E4bp4 transgene compared with that in transgene-negative CD4 + T cells, whereas IL-4 production was the same in both cell types (Fig. 3c) . Moreover, retroviral overexpression of E4bp4 induced the production of IL-10 as well as of IL-13 in T H 1 cells (Fig. 3d,e) . These results suggested that E4BP4 'preferentially' induces the expression of both Il10 and Il13.
E4BP4 is essential for the expression of Il10 and Il13
Given their apparent coregulation by E4BP4, we next examined the production of both IL-10 and IL-13 in R4 T H 1 cells. Repetitive T H 1 priming induced both cytokines (Fig. 4a) . To assess whether the expression of Il10 and Il13 required E4BP4 expression in T H 1 cells, we used a retrovirus vector encoding short hairpin RNA (shRNA) specific for E4bp4 to suppress its expression. Knockdown of E4bp4 under T H 1-skewing conditions markedly inhibited the production of IL-10 and IL-13 normally observed after the third or fourth round of stimulation but had no effect on IFN-γ production during the first round of stimulation (Fig. 4b) , which indicated that E4BP4 is the critical factor that regulates the production of both IL-10 and IL-13 in chronically activated T H 1 cells.
To better understand the mechanistic effects of E4BP4 on T cell function, especially in terms of regulation of cytokine production, we generated mice lacking E4bp4 (Supplementary Fig. 6a ). The development of thymic T cells and splenic T cells and B cells in E4bp4-deficient mice was similar to that of their littermates ( Supplementary  Fig. 6b) . Moreover, T cell proliferation after TCR engagement and the expression profiles of the T cell-activation markers CD25 and Fig. 6c,d ). In contrast, there was significantly less production of IL-10 and IL-13 by R4 T H 1 cells derived from the E4bp4 −/− mice than by those from their littermates (Fig. 4c) . We next examined the effect of E4bp4 deficiency on the differentiation of T H 1, T H 2, T H 17 and induced T reg cells. E4bp4 −/− T cells showed normal production of IFN-γ, IL-4 and IL-1,7 as well as normal induction of T reg cells by transforming growth factor-β ( Supplementary Fig. 6e and data not shown). Mouse memory T H 1 cells and human T H 1 cells produce IL-13 when they are generated in the presence of IL- 18 (refs. 32,33) . However, E4BP4 is dispensable for IL-18-induced IL-13 production, because E4bp4 −/− T H 1 cells expressed IL-13 after stimulation with IL-18 ( Supplementary Fig. 7a ). IL-10 production by T H 1 cells after stimulation with IL-27 has also been reported 34 . Indeed, control T H 1 cells expressed IL-10 in the presence of IL-27, whereas E4bp4 −/− T H 1 cells did not (Supplementary Fig. 7b) . Moreover, although IL-10 production has been reported in T H 17-polarizing conditions 35 , we were unable to confirm that result (Supplementary Fig. 7c) . Therefore, all these data support the hypothesis that E4BP4 is required for IL-13 expression by T H 1 cells in which plasticity has been induced by chronic stimulation and for IL-10 expression when plasticity is induced by IL-27 stimulation.
E4BP4 regulates Il10 expression by T H 2 cells
Next we analyzed the role of E4BP4 in the production of IL-10 and IL-13 by T H 2 cells. We obtained naive T cells from E4bp4 −/− or wildtype mice and stimulated the cells under T H 2-polarizing conditions. About 50% of the E4bp4 +/+ T cells generated under T H 2 conditions produced IL-13 or IL-10, ~20% of the IL-4 + cells were also IL-10 + , and ~25% of the IL-13 + cells also produced IL-10. In contrast, the population of IL-10 + cells among the E4bp4 −/− T H 2 cells, was much smaller than that of cells from the wild-type littermates (Fig. 5a) , although the production of IL-4, IL-5 and IL-13 by these cells was similar to that of wild-type T cells (Fig. 5b,c) .
To further confirm that the effect of E4BP4 on CD4 + T cells was intrinsic, we crossed mice transgenic for Cd4-driven expression of Cre recombinase (Cd4-Cre) with our mouse line with conditional deficiency in E4bp4 to generate mice with CD4 + T cell-specific deletion of E4bp4 (E4bp4 f/f Cd4-Cre mice); although the deletion of E4bp4 in CD4 + T cells was partial, it was still greater than 80% (Supplementary Fig. 6a) . Again, IFN-γ production by E4bp4 f/f Cd4-Cre T H 1 cells and the expression of IL-4 and IL-13 by E4bp4 f/f Cd4-Cre T H 2 cells were similar to that of the Cd4-Cre control mice. However, IL-10 expression in T H 2 cells was much lower than that of the Cd4-Cre control cells (Fig. 5d) . As expected, neither wild-type nor E4bp4 f/ f Cd4-Cre T H 1 cells had detectable production of IL-10.
We next determined whether the production of IL-10 or IL-13 by T cells was also dependent on GATA-3. To determine if E4BP4 requires GATA-3 for IL-10 production, we transduced E4bp4 +/+ and E4bp4 −/− T cells with a Gata3-expressing retroviral vector. Exogenous Gata3 induced the generation of IL-10-producing E4bp4 +/+ T cells slightly, but the response was completely abolished in E4bp4 −/− T cells (Fig. 5e, top row) . In addition, we transduced a retroviral vector expressing Cre into T cells with loxP-flanked Gata3 (Gata3 f/f ) and into wild-type C57BL/6 T cells. We further transduced cells with a retroviral vector expressing E4bp4 and found that ectopic expression of E4BP4 protein significantly induced the development of IL-10 + T cells with or without Gata3 expression (Fig. 5e, bottom) . We further examined the production of IL-10 and IL-13 by T H 1 cells using CD4 + T cells derived from Gata3 f/f Cd4-Cre mice. IL-13 production in R4 T H 1 cells lacking Gata3 was ~50% lower, but there was no effect on IL-10 production (Fig. 5f) . These results indicate that E4BP4 is a critical factor for Il10 expression in CD4 + T cells independently of Gata3 expression and that Il13 expression in T H 1 cells requires low Gata3 expression.
E4BP4 regulates the expression of Il13 and Il10 in NKT cells
Various T cell subsets, including NKT cells and T reg cells, produce IL-10 and IL-13, and we hypothesized that E4BP4 is a regulator of the expression of Il10 and Il13 in these cells as well. To test our hypothesis, we first determined if there was a correlation between the expression E4bp4 and the expression of both Il10 and Il13 by NKT cells. We stimulated whole splenocytes with the NKT cell ligand α-galactosyl ceramide (α-GalCer) and analyzed cytokine production cells by ICS after gating on cells that recognized a dimer of α-GalCer and the antigen-presenting molecule CD1d. About 55% of NKT cells produced IL-13, and all of the IL-10-producing cells also produced IL-13 ( Fig. 6a) . We also observed that E4bp4 expression was induced by stimulation with α-GalCer, which suggested a possible role for E4BP4 in the expression of Il10 and Il13 by NKT cells. It has been reported that the treatment of IL-17RB + NKT cells with IL-25 induces high Il13 expression 36 ; therefore, we focused on a possible role for E4BP4 in inducing the expression of Il10 and Il13 in this NKT cell subset. We isolated IL-17RB + NKT cells from BALB/c mice and stimulated the cells with IL-25 in the presence of DCs. E4bp4 expression was induced considerably in the IL-25-treated cells, and its expression correlated well with the expression of Il10 and Il13 (Fig. 6b) . The frequency of splenic NKT cells was nearly identical in E4bp4 −/− and wild-type mice (Fig. 6c) ; however, in response to stimulation with α-GalCer, E4bp4 −/− NKT cells had no detectable IL-10 expression and lower IL-13 expression, and in response to IL-25, E4bp4 −/− NKT cells had lower IL-13 expression and both wild-type and E4bp4 −/− NKT cells had no detectable IL-10, whereas the expression of IFN-γ and IL-4 was unaffected (Fig. 6d) .
To study the involvement of E4BP4 in IL-10 production by T reg cells, we isolated naive CD4 + T cells (Foxp3 − CD44 lo CD62L hi ), memory CD4 + T cells (Foxp3 − CD44 hi CD62L lo ) and natural T reg cells (Foxp3 + CD25 − or Foxp3 + CD25 hi ) from mice expressing the transcription factor Foxp3 from a human CD2 reporter (Foxp3 hCD2 mice) 37 , which allowed better separation of Foxp3 + cells from other live cells on the basis of the expression of human CD2, and stimulated the cells through the TCR. Natural T reg cells expressed IL-10 but not IL-13 after stimulation of the TCR (Supplementary Fig. 8a ). We found high expression of E4bp4 in Il10-expressing natural T reg cells, particularly in the CD25 − subset, and we also detected this in memory T cells, which also expressed Il10. In contrast, naive T cells had low expression of both E4bp4 mRNA and Il10 mRNA (Supplementary Fig. 8a ). IL-10 production was impaired in natural T reg cells and memory T cells derived from E4bp4 −/− mice, but IL-13 production was not (Fig. 6e,f and Supplementary Fig. 8b,c) . These results indicate that E4bp4 expression is correlated with the expression of Il10 and Il13 by NKT cells, memory T cells and IL-10-expressing natural T reg cells, which suggests that E4BP4 regulates Il10 expression in all T cell subsets and Il13 expression in NKT cells.
E4BP4 binds specifically to the Il13 and Il10 loci
The Il4 locus in T H 1 cells is thought to be maintained in a repressed state by epigenetic modifications 38 . However, as shown above, chronic T H 1 stimulation promoted IL-13 production, which suggests that the Il13 and Il4 loci may have distinct modes of regulation. Therefore, we studied methylation and histone modifications of the Il13 locus in T H 1 cells. The Il13 distal promoter contains two well characterized DNase I-hypersensitive sites, HS1 and HS2, which are highly conserved in mammals. We used a bisulfite-sequencing PCR assay to investigate the DNA-methylation status, especially of the HS1 region, in naive T cells and in developing T H 1 and T H 2 cells (Fig. 7a) . Most CpG dinucleotides were equally unmethylated in naive CD4 + cells; however, we observed a few methylated sites in both developing T H 1 cells and T H 2 cells (Fig. 7a) . We also investigated histone modification of the Il13 and Il4 loci in various T H 1 cell developmental stages by chromatin immunoprecipitation (ChIP) and found considerable enrichment of histone H3 trimethylated at Lys4 in the HS1 region of the Il13 promoter, even in T H 1 cells stimulated for 1 week (R1; Fig. 7b, top) . We then used ChIP analysis with nuclear extracts prepared from conventional T H 1 and R4 T H 1 cells to determine whether E4BP4 binds to the Il13 promoter. There was considerable enrichment of specific binding of E4BP4 to the HS1 site in R4 T H 1 cells but not in conventional T H 1 cells (Fig. 7b, bottom) . We then used electrophoretic mobility-shift assay to identify the putative E4BP4-binding site on the Il13 promoter. We prepared nuclear extracts of R4 T H 1 cells and T H 2 cells and tested for binding of E4BP4 to oligonucleotides corresponding to the putative binding sites in the adenovirus E4 promoter and the mouse Il13 promoter. We found a distinctly shifted band in T H 2 cells and a slight sift even in T H 1 cells (Fig. 7c) . This binding was blocked by treatment with either antibody to E4BP4 (anti-E4BP4) or an excess of unlabeled competitor oligonucleotide corresponding to the HS1 site of the Il13 promoter (Fig. 7c) . The HS1 site corresponds to a conserved GATA-3-response element (CGRE) identified as a distal promoter for Il13, and CGRE contains a consensus E4BP4-binding sequence as well as a GATA-3-binding site 39 . We found that 2-kilobase fragments including the CGRE had strong promoter activity in a TCR-stimulation assay, and deletion of the CGRE from the promoter region attenuated this activity even when E4bp4 was overexpressed (Supplementary Fig. 9a) . Thus, binding of E4BP4 to the CGRE regulates Il13 promoter activity. Together these results demonstrate that binding of E4BP4 to the CGRE site of the Il13 promoter promotes the expression of IL-13 in T cells. The HS1 site in the Il13 promoter is transcriptionally permissive even in T H 1 cells, which suggests that E4BP4 expression may directly govern the plasticity of Il13 in T H 1 cells.
We next did a similar study of the Il10 locus, in which we identified 15 possible binding sites on the basis of the predicted E4BP4-binding sequence (Fig. 7d) . ChIP analysis showed enrichment for histone H3 acetylated at Lys9 or Lys14 in some of the binding sites. We observed such enrichment in these regions mainly in T H 2 cells but not in conventional T H 1 cells. Further ChIP analysis showed that E4BP4 bound to intron 4 and the 3′ noncoding region of the Il10 locus (Fig. 7d) . Two 5′ upstream fragments of Il10 400 and 1,000 in length that do not contain consensus binding sequences for E4BP4 had no promoter activity in the T cell-activation assay (Supplementary Fig. 9a) , which indicated that E4BP4 does not regulate the activation-induced promoter activity. To unequivocally demonstrate a role for E4BP4 in the epigenetic modification of the Il10 locus, we analyzed E4bp4 −/− cells. The strong enrichment for acetylated histone H3 in the Il10 locus noted above was completely absent from E4bp4 −/− T H 2 cells (Fig. 7e) . From these results, we conclude that E4BP4 directly regulates the permissive status of the Il10 locus at the chromatin level.
E4BP4 in the control for autoimmune responses
Mice with complete ablation of Il10 or T cell-specific ablation of Il10 (Il10 f/f Cd4-Cre mice) develop spontaneous intestinal inflammation 40 , IL-10 (Fig. 8a) . Given those findings, we examined the involvement of E4BP4 in T cells in a T cell-transfer colitis model in which we reconstituted lymphopenic mice deficient in recombination-activating gene 1 with CD4 + CD44 hi CD62L lo CD25 − naive T cells from control littermate mice or E4bp4 −/− mice and monitored the recipient mice for the development of inflammatory disease. Mice reconstituted with control T cells gained weight for the first 2 weeks but then began to gradually lose weight (Fig. 8b) . In contrast, mice reconstituted with E4bp4 −/− T cells gained less weight and had more severe weight loss and a worse clinical score, including death (two of ten mice; Fig. 8b) . Five of the ten mice reconstituted with E4bp4 −/− T cells began to have diarrhea after 4 weeks (data not shown). We confirmed the clinical symptoms by evaluating colonic inflammation morphologically and by histology (Fig. 8c) and also found that E4bp4 −/− T cells derived from intestinal lymph nodes and colon did not express IL-10 ( Fig. 8d) . Thus, regulation of IL-10 in T cells by E4BP4 is important for tolerance induction to prevent the development of chronic inflammatory disease in the colon. We further examined the importance of the regulation of IL-10 by E4BP4 in an experimental autoimmune encephalomyelitis (EAE) model. We immunized E4bp4 −/− mice and their control littermates with a peptide of myelin oligodendrocyte glycoprotein (amino acids 35-55) emulsified in complete Freund's adjuvant. Control and E4bp4 −/− mice showed notable EAE development that reached a maximum at 15 d (Fig. 8e) . Control mice began to recover, showing improvement in their clinical scores after 25 d. In contrast, E4bp4 −/− mice showed no evidence of recovery and had worse EAE scores after 30 d (Fig. 8e) . E4bp4 −/− T cells from the regional lymph node expressed no IL-10 and had a slightly more IL-17 production (Fig. 8f) . We further monitored Il10 transcription in mice with ongoing disease using a reporter system in which sequence encoding the yellow fluorescent protein Venus was knocked into the 3′ untranslated region of the Il10 locus 41 . Fewer E4bp4 −/− T cells from the spleen, among intestinal intraepithelial lymphocytes or from the lamina propria or bone marrow produced IL-10 than did those from control mice (Supplementary Fig. 10 ). Therefore, E4BP4 induction of IL-10 is also important for EAE remission.
DISCUSSION
We have demonstrated here that chronic antigen stimulation resulted in plasticity of T H 1 cells, which then secreted certain T H 2 cytokines, including IL-10 and IL-13, but not IL-4 or IL-5. Acquisition by T H 1 cells of the ability to express IL-10 and IL-13 was regulated by E4BP4, whose own expression was upregulated by chronic antigenic stimulation. E4BP4 also regulated the production of IL-10 and IL-13 in NKT cells, memory T cells and T reg cells. In contrast, Il13 regulation in T H 2 cells was totally independent of E4BP4, which indicated that E4BP4 regulates Il13 differently in distinct CD4 + T cell subsets but commonly regulates Il10 in all CD4 + T cells. Therefore, we propose that E4BP4 has multiple functions in the regulation of genes encoding cytokines and is a transcriptional factor essential to the regulation of IL-10 production. Our results provide the new insight that different T H 2 cytokines are regulated independently by a distinct combination of transcription factors in different T cell subsets.
During the past two decades, it has become widely accepted that Il10 and Il13 are controlled together with Il4 by common transcriptional mechanisms. This idea has been supported by many observations; for example, that upregulation of Gata3 expression is essential for the expression of IL-4 and IL-13 in T H 2 cells 42 , and that conditional deletion of Gata3 in activated CD4 + T cells attenuates the production of both cytokines 22 . However, we found no defect in IL-13-induced airway hyper-responsiveness in Il4 −/− mice, which completely lack T H 2 cells, which indicated that T H 2 cells are not the source of IL-13 under certain conditions 43, 44 . The source of IL-13 in Il4 −/− mice has thus far remained unknown, but our study has shown that because of their plasticity, T H 1 cells are an alternative source of this cytokine. In terms of IL-10, its production by T H 1 cells has been reported after chronic infection with T. gondii or L. major 13, 15 . IL-10 production is thus induced by relatively strong chronic stimulation, as in parasite infection, and this is consistent with our data showing that chronic antigen stimulation induced the expression of E4BP4, which controls the production of IL-10 and IL-13 by T H 1 cells.
E4bp4 is expressed mainly by T H 2 cells 29, 30 , and we have demonstrated that E4bp4 expression was controlled by the IL-4-STAT6 pathway. However, the question of how chronic T H 1 stimulation induces E4bp4 expression remains. A published report has indicated that calcium signaling-mediated activation of the transcription factor NFAT induces E4bp4 expression 45 , and Nfat5 was one of the genes we found was induced by repetitive stimulation, although its overexpression did not induce E4bp4 expression. None of the 15 other candidate genes that showed differences in upregulation in R4 T H 1 cells affected E4bp4 expression; therefore, further investigation is need to clarify how chronic T H 1 stimulation induces E4bp4 expression.
E4BP4 was originally identified as a negative regulator of the mammalian circadian oscillatory system 23 . E4bp4 −/− mice were born at normal Mendelian ratios and grew normally, which indicated that deficiency in E4BP4 has no severe phenotypic consequences except the spontaneous development of mild diarrhea. In the absence of E4BP4, the phenotype of CD4 + T cells, including NKT cells, was fairly normal, consistent with the published observation that deletion of E4bp4 affects mainly NK cell development with no change in the proportion of other T cell lineages 26, 27 . T cells lacking E4bp4 had normal T H 1, T H 2, induced T reg and T H 17 differentiation, although the proportion of T H 1 cells and T H 2 cells was slightly lower than that in wild-type mice. E4bp4-deficient T H 2 cells were considerably impaired in IL-10 production but not in GATA-3 expression or the production of other T H 2 cytokines such as IL-4 and IL-5, and IL-13 production was even enhanced in E4bp4 −/− T H 2 cells.
GATA-3 directly regulates the Il13 promoter 20 and, furthermore, conditional deletion of Gata3 in T H 2-committed T cells completely attenuates Il13 expression 22, 31 , which suggests that GATA-3 is indispensable for Il13 transcription in T H 2 cells but E4BP4 is not. In contrast, E4BP4 was absolutely required for IL-13 expression in T H 1 cells. The distal Il13 promoter, CGRE, 1.4-1.8 kilobases upstream of exon 1, contains 42 CpG dinucleotides 46 , and analysis of DNA dimethylation and methylation of histone H3 at Lys4 indicated that the CGRE is transcriptionally accessible in naive T cells, T H 1 cells and T H 2 cells. Reporter assays indicated the activity of this promoter is regulated by E4BP4. Therefore, IL-13 production by T H 1 cells seems to be determined by the regulation of the promoter at the level of E4BP4 expression rather than by epigenetic regulation.
We have demonstrated that E4BP4 was also essential for IL-10 expression in most of the CD4 + subsets we examined. The precise mechanism by which IL-10 expression is regulated in T cells has remained unclear, although a contribution by GATA-3 has been demonstrated by retroviral overexpression experiments 21 . Our data indicated that E4BP4 induced IL-10 production in the absence of GATA-3, which suggests that GATA-3 is dispensable for IL-10 production. Therefore, E4BP4 seems to be an essential regulator of IL-10 expression not only in T H 2 cells but also in T H 1 cells, which typically have very low expression of GATA-3. However, unlike its binding to Il13, E4BP4 did not bind to the Il10 promoter region, binding instead to an intronic region and a 3′ noncoding sequence, both of which are well conserved between humans and mice. T H 2 cells lacking E4BP4 had no permissive chromatin structure in these regions, which suggests that Il10 is epigenetically regulated by E4BP4 binding. However, T cells are not the only source of IL-10, and IL-10 is reported to be secreted by NK cells, regulatory B cells and regulatory DCs. Indeed, regulatory DCs from the lamina propria of E4bp4 −/− mice had lower expression of IL-10 (data not shown), which suggests that E4BP4 may function as a common transcriptional regulator for IL-10 production in a variety of cell types.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
